Search
Stories, the companies and people Loro tracks, and the primary records behind them — filings, donations, contracts and disclosures.
Company or person15
Chang Michelle
Company
Gass Michelle
Company
Dilley Michelle
Company
Link Michelle F.
Company
Chen Michael
Company
McShane Geri-Michelle
Company
HOWARD MICHELLE J
Company
Lohmeier Michelle
Company
Cho Michael
Company
O'Connor Michele
Company
Barbeau Michelle Marie
Company
Carl H Michel
Person
Chang Amy
Company
Miller Elizabeth Michelle
Company
COLE MICHAEL R
Company
Primary record11
Chang Michelle filed 4
SEC form 4 filed by Chang Michelle (CIK 2040959) on 2026-10-23.
Chang Michelle filed 4
SEC form 4 filed by Chang Michelle (CIK 2040959) on 2026-10-13.
insider_trade
National Storage Mechanism | Additional information RNS Number : 7941X Shuka Minerals PLC 06 October 2026 Shuka Minerals Plc (“Shuka” or the “Company”) 6 October 2026 Conversion of Loan & Issue of Equity Director/PDMR Sh
NIKE, Inc. filed 8-K
Item 5.02 – Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On July 15, 2026, the Board of Directors of NIKE, Inc. (the “
Digital Turbine, Inc. filed 8-K
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers (e) On August 25, 2026, at the annual stockholders meeting of Di
Eos Energy Enterprises, Inc. filed 8-K
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Chief Commercial Officer Transition On August 24, 2026, Eos Ene
STEMPOINT CAPITAL LP filed SCHEDULE 13G
on May 6, 2026, plus 70,158 shares of Common Stock which may be acquired upon the exercise of Series A Warrants, 64,150 shares of Common Stock which may be acquired upon the exercise of Series B Warrants, and 195,000 sha
STEMPOINT CAPITAL LP filed SCHEDULE 13G/A
on May 12, 2026, plus 343,154 shares of Common Stock which may be acquired upon the exercise of the Pre-Funded Warrants, 142,856 shares of Common Stock which may be acquired upon the exercise of Series A Warrants, and 14
Cellectar Biosciences, Inc. filed SCHEDULE 13G
on June 2, 2026, plus 490,802 shares of Common Stock which may be acquired upon the exercise of the Pre-Funded Warrants, which are subject to the Beneficial Ownership Limitation, which amount has been added to the shares
Faeth Therapeutics, Inc. filed SCHEDULE 13G/A
on June 18, 2026. -0- 0. -0- 0. N Y Y Y Y Y N By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and we
OSHKOSH CORP filed SCHEDULE 13G/A
, due to its discretionary power to make investment decisions over such shares for its clients and/or its ability to vote such shares. In all cases, persons other than Aristotle Capital Management, LLC have the right to